文献速递淋巴瘤浆细胞疾病

伴浆细胞与记忆B细胞特征的华氏巨球蛋白血症两种DNA甲基化亚型鉴定

Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features.
PubMed 文献 · Blood · 2020-01-01

该研究整合35例MYD88突变华氏巨球蛋白血症(WM)患者的全基因组DNA甲基化、转录组、突变及表型特征,与正常浆细胞和B细胞亚群比较,发现患者按DNA甲基化模式自然分为两类,分别类似正常记忆B细胞(MBC)和浆细胞(PC)特征,且两亚型在遗传学、表型和临床特征上存在差异。

要点

  • WM患者按DNA甲基化模式自然分为MBC样和PC样两个亚型。
  • MBC样WM富集PU.1、TCF3和OCT2基序,MYD88/TLR通路活性升高。
  • PC样WM呈现全局低甲基化和组蛋白基因选择性过表达。

核心结论

  • 研究结果说明了一种利用DNA甲基化对WM患者进行亚分类的新方法,并揭示了WM患者间存在不同的分子特征。

研究设计与样本

  • 研究整合了35例MYD88突变WM患者的肿瘤细胞全基因组DNA甲基化、转录组、突变和表型特征,并与正常浆细胞和B细胞亚群进行比较。

主要发现

  • 患者按DNA甲基化模式自然分为2组,分别与正常MBC和PC特征相关。
  • MBC样WM的增强子区域发生选择性重编程,低甲基化富集于PU.1、TCF3和OCT2转录因子基序,并涉及MYD88/TLR通路活性升高。
  • PC样WM显示显著全局低甲基化及组蛋白基因选择性过表达。
  • MBC样WM具有更多克隆性CXCR4突变(P = .015)、13q缺失(P = .006)、脾肿大(P = .02)和血小板减少(P = .004)。
  • PC样WM具有更多6q缺失(P = .012)、6p获得(P = .033),以及更高频率的IGHV3基因(P = .002)、CD38表达(P = 4.1e-5)和浆细胞分化特征(P = .008)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epigenetic changes during B-cell differentiation generate distinct DNA methylation signatures specific for B-cell subsets, including memory B cells (MBCs) and plasma cells (PCs). Waldenström macroglobulinemia (WM) is a B-cell malignancy uniquely comprising a mixture of lymphocytic and plasmacytic phenotypes. Here, we integrated genome-wide DNA methylation, transcriptome, mutation, and phenotypic features of tumor cells from 35 MYD88-mutated WM patients in relation to normal plasma and B-cell subsets. Patients naturally segregate into 2 groups according to DNA methylation patterns, related to normal MBC and PC profiles, and reminiscent of other memory and PC-derived malignancies. Concurrent analysis of DNA methylation changes in normal and WM development captured tumor-specific events, highlighting a selective reprogramming of enhancer regions in MBC-like WM and repressed and heterochromatic regions in PC-like WM. MBC-like WM hypomethylation was enriched in motifs belonging to PU.1, TCF3, and OCT2 transcription factors and involved elevated MYD88/TLR pathway activity. PC-like WM displayed marked global hypomethylation and selective overexpression of histone genes. Finally, WM subtypes exhibited differential genetic, phenotypic, and clinical features. MBC-like WM harbored significantly more clonal CXCR4 mutations (P = .015), deletion 13q (P = .006), splenomegaly (P = .02), and thrombocytopenia (P = .004), whereas PC-like WM harbored more deletion 6q (P = .012), gain 6p (P = .033), had increased frequencies of IGHV3 genes (P = .002), CD38 expression (P = 4.1e-5), and plasmacytic differentiation features (P = .008). Together, our findings illustrate a novel approach to subclassify WM patients using DNA methylation and reveal divergent molecular signatures among WM patients.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Roos-Weil D, Giacopelli B, Armand M, et al. Identification of 2 DNA methylation subtypes of Waldenström macroglobulinemia with plasma and memory B-cell features. Blood. 2020. PMID: 32457988. doi:10.1182/blood.2020005081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。